Transarterial Chemoembolization [topp]    
Survival [acty]    
patient [podg]    
Metastatic Carcinoma [neop]    
Hepatocellular [qlco]    
Propensity Score [qnco]    
match [resa]    
Analysis [lbpr]    
asian countries [geoa]    
Transarterial Chemoembolization [topp]    
Applied [hlca]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Hepatic metastasis [neop]    
absence [qnco]    
Main portal vein [bpoc]    
Thrombosis [patf]    
Survival [acty]    
Benefit [qnco]    
studies [mnob]    
Aim [idcn]    
To [qlco]    
Role [socb]    
Transarterial Chemoembolization [topp]    
patient [podg]    
Metastatic Carcinoma [neop]    
Hepatocellular [qlco]    
+2 [qnco]    
Consecutive [qlco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Review [inpr]    
Liver Cancer [neop]    
c stage [inpr]    
patient [podg]    
Hepatic metastasis [neop]    
Initial presentation [ftcn]    
Main portal vein [bpoc]    
Thrombosis [patf]    
include [ftcn]    
Receive [qlco]    
Transarterial Chemoembolization [topp]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
Receive [qlco]    
Support [cnce]    
treatment [ftcn]    
Control Group [grup]    
Factor [ftcn]    
Associated [qlco]    
Survival [acty]    
Evaluable [ftcn]    
Multivariate Analysis [qnco]    
Survival [acty]    
Two [qnco]    
Group [idcn]    
Compare [acty]    
Propensity Score [qnco]    
match [resa]    
Analysis [lbpr]    
median [spco]    
Survival [acty]    
Transarterial Chemoembolization [topp]    
Control Group [grup]    
6/6 [fndg]    
3 Months [tmco]    
Multivariate Analysis [qnco]    
Transarterial Chemoembolization [topp]    
Hazard Ratio [qnco]    
size tumor [spco]    
Hazard Ratio [qnco]    
1+ [qnco]    
+2 [qnco]    
ng/mL [qnco]    
1+ [qnco]    
Hazard Ratio [qnco]    
1+ [qnco]    
Factor [ftcn]    
Associated [qlco]    
Survival [acty]    
Propensity Score [qnco]    
match [resa]    
Analysis [lbpr]    
Better [qlco]    
Survival [acty]    
Note [clna]    
Transarterial Chemoembolization [topp]    
Group [idcn]    
median [spco]    
Survival [acty]    
3 Months [tmco]    
subgroup [virs]    
Analysis [lbpr]    
Show [inpr]    
patient [podg]    
size tumor [spco]    
Part [spco]    
Thousand [qnco]    
Currency [mnob]    
alpha fetoprotein levels [lbtr]    
Part [spco]    
Thousand [qnco]    
Currency [mnob]    
ng/mL [qnco]    
1+ [qnco]    
Best [qlco]    
Survival [acty]    
Transarterial Chemoembolization [topp]    
Smaller [qlco]    
size tumor [spco]    
Only [qnco]    
Independence [idcn]    
Predictor [idcn]    
Survival [acty]    
Long [qlco]    
month [tmco]    
patient [podg]    
Receive [qlco]    
Transarterial Chemoembolization [topp]    
Transarterial Chemoembolization [topp]    
provides [food]    
Survival [acty]    
Benefit [qnco]    
Metastatic Carcinoma [neop]    
Hepatocellular [qlco]    
patient [podg]    
prospective [resa]    
To [qlco]    
Role [socb]    
Combination [mnob]    
Transarterial Chemoembolization [topp]    
treatment [ftcn]    
Metastatic Carcinoma [neop]    
Hepatocellular [qlco]    
